drugset
Drugs / COVID-19 mRNA Vaccine Moderna
last change Feb 2023 re-read 3 minutes ago

COVID-19 mRNA Vaccine Moderna

Vaccine

Developed for
COVID-19
Investigated by
Bioster, a.s. · Sanofi Pasteur, a Sanofi Company · University Hospital of Saint-Etienne

Trials 1

today NCT05047718 · Ph 4
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05047718 Oct 2021 → Aug 2022 COVID-19 University Hospital of Saint-Etienne Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as COVID-19 mRNA Vaccine Moderna ClinicalTrials.gov intervention name — accepted as the source's own label NCT05047718 ↗
Modality Vaccine “COVID-19 mRNA Vaccine Moderna (3 doses)” NCT05047718 ↗